Inter-species variation in hepatocyte activation of 2-acetylaminofluorene in salmonella mutagenicity assays with TA98 and TA98/1,8DNP6

Arce, 1987, The 32P-post-labelling method in quantitative DNA adduct disimetry of 2-acetylaminofluorene-induced mutagenicity in Chinese hamster ovary cells and Salmonella typhimurium TA1538, Carcinogenesis, 8, 515, 10.1093/carcin/8.4.515 Astrom, 1986, Induction of cytochrome P-450 and related drug metabolising activities in the livers of different rodent species by 2-acetylaminofluorene and by 3-methylcholanthrene, Biochem. Pharmac., 35, 2703, 10.1016/0006-2952(86)90178-4 Beranek, 1982, Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene, 79, 5175 Berry, 1969, High-yield preparation of isolated rat liver parenchymal cells; a biochemical and fine structural study, J. Cell Biol., 43, 506, 10.1083/jcb.43.3.506 Boyd, 1984, Evidence for a 1-electron mechanism of 2-aminofluorene oxidation by prostaglandin H synthase and horseradish peroxidase, J. biol. Chem., 259, 13885, 10.1016/S0021-9258(18)89829-5 Brouns, 1980, Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells. Involvement of different metabolites causing DNA repair and bacterial mutagenesis, Archs Toxicol., 45, 53, 10.1007/BF00303295 Flammang, 1985, Acetyl CoA-dependent, cytosol-catalysed binding of carcinogenic N-hydroxy-arylamines to DNA, 190 Fry, 1979, Use of primary hepatocyte cultures in biochemical toxicology, 201 Garner, 1984, Carcinogenic aromatic amines and related compounds, Vol. 1, 175 Gayda, 1981, Activation of aflatoxin B1 by primary cultures of adult rat hepatocytes: effects of hepatocyte density, Chemico-Biol. Interactions, 35, 255, 10.1016/0009-2797(81)90001-6 Green, 1977, Mutagen screening by a simplified bacterial fluctuation test: use of microsomal preparations and whole liver cells for metabolic activation, Mutation Res., 48, 287, 10.1016/0027-5107(77)90171-3 Heflich, 1986, Relationships between the DNA adducts and the mutations and sister-chromatid exchanges produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N-hydroxy-N′-acetylbenzidine and 1-nitrosopyrene, Mutagenesis, 1, 201, 10.1093/mutage/1.3.201 Holme, 1983, Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system, Mutation Res., 117, 113, 10.1016/0165-1218(83)90158-1 Holme, 1985, Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-hydroxy-2-acetylaminofluorene, Carcinogenesis, 6, 421, 10.1093/carcin/6.3.421 Holme, 1986, Species differences in the metabolism of 2-acetylaminofluorene by hepatocytes in primary monolayer culture, Cancer Res., 46, 1627 Hultin, 1987, Genetic variability in deacetylation of 2AAF and NOH-2AAF in inbred strains of mice, Carcinogenesis, 8, 1939, 10.1093/carcin/8.12.1939 Ioannides, 1981, Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species. Role of cytochrome P-450 and P-448, Xenobiotica, 11, 701, 10.3109/00498258109049090 Irving, 1966, Enzymatic deacetylation of N-hydroxy-2-acetylaminofluorene by liver microsomes, Cancer Res., 26, 1390 Kaneda, 1981, Species differences in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide, J. natn. Cancer Inst., 67, 549 Lai, 1987, Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulphooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts, Carcinogenesis, 8, 471, 10.1093/carcin/8.3.471 Lai, 1985, N-sulphooxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J × C3H/HeJ F1 (B6C3F1) mice, Carcinogenesis, 6, 1037, 10.1093/carcin/6.7.1037 Langenbach, 1978, Liver cell-mediated mutagenesis of mammalian cells by liver carcinogens, 75, 2864 Langenbach, 1983, The use of intact cellular activation systems in genetic toxicology assays, 71 Lower, 1976, Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species, J. Toxicol. envir. Hlth, 1, 421, 10.1080/15287397609529341 McCoy, 1984, Role of metabolism on the mutagenicity of nitroarenes, 57 McGregor, 1975, The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential, Mutation Res., 30, 305, 10.1016/0027-5107(75)90001-9 Maron, 1983, Revised methods for the Salmonella mutagenicity assay, Mutation Res., 113, 173, 10.1016/0165-1161(83)90010-9 Maslansky, 1983, DNA repair in hepatocyte primary cultures derived from the rat, mouse, hamster, guinea pig and rabbit, 451 Miller, 1978, Some current perspectives on chemical carcinogenesis in humans and experimental animals, Cancer Res., 38, 1479 Mirsalis, 1980, Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo-in vitro assay for potential carcinogens and mutagens, Carcinogenesis, 1, 621, 10.1093/carcin/1.7.621 Moldeus, 1978, Isolation and use of liver cells, Meth. Enzymol., 52, 60, 10.1016/S0076-6879(78)52006-5 Neis, 1986, Activation of mutagens by hepatocytes and liver 9000 × g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations, Mutation Res., 164, 41, 10.1016/0165-1161(86)90040-3 Orr, 1985, Dinitropyrene-resistant Salmonella typhimurium are deficient in an acetyl-CoA acetyltransferase, Chemico-Biol. Interactions, 54, 281, 10.1016/S0009-2797(85)80169-1 Paterson, 1987, Activation of 2-amino-3-methylimidazo-[4,5-f]quinoline in rat and human hepatocyte/Salmonella mutagenicity assays: the contribution of hepatic conjugation, Mutagenesis, 2, 137, 10.1093/mutage/2.2.137 Poirier, 1982, Formation and removal of (guan-8-yl)-DNA-2-acetylaminofluorene adducts in liver and kidney of male rats administered dietary 2-acetylaminofluorene, Cancer Res., 42, 1317 Razzouk, 1982, Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea-pig liver microsomes, Cancer Res., 42, 4712 Saito, 1985, Metabolic activation of mutagenic N-hydroxyarylamines by 0-acetyltransferase in Salmonella typhimurium TA98, Archs Biochem. Biophys., 239, 286, 10.1016/0003-9861(85)90838-0 Sato, 1981, Selective induction of microsomal 2-acetylaminofluorene N-hydroxylation by dietary 2-acetylaminofluorene in rats, Carcinogenesis, 2, 571, 10.1093/carcin/2.7.571 Schut, 1978, Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat, Molec. Pharmac., 14, 682 Seglen, 1976, Preparation of isolated rat liver cells, Meth. Cell Biol., 13, 29, 10.1016/S0091-679X(08)61797-5 Sirica, 1980, Drug metabolism and effects of carcinogens in cultured hepatic cells, Pharmac. Rev., 31, 205 Smith, 1988, Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models, Mutagenesis, 3, 323, 10.1093/mutage/3.4.323 Smith, 1988, Detection of DNA damage in rat but not guinea pig hepatocytes in the in vivo-in vitro DNA repair assay with 2-acetylaminofluorene. (Abstract), Mutagenesis, 3, 450 Smith, 1988, Efficacy of the Salmonella mutagenicity assay in the detection of N-acetoxyarylamines, Hum. Toxicol. Snyder, 1987, Comparison of metabolic activation of carcinogens in human, rat, and hamster hepatocytes, Mutation Res., 182, 31, 10.1016/0165-1161(87)90005-7 Steward, 1985, Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes, Molec. Pharmac., 27, 125 Takeishi, 1979, Mutagenic activation of 2-acetylaminofluorene by guinea pig liver homogenates: essential involvement of cytochrome P-450 mixed function oxidases, Mutation Res., 62, 425, 10.1016/0027-5107(79)90038-1 Thorgeirsson, 1984, Metabolic processing of aromatic amides, 183 Visser, 1981, Partial persistency of 2-aminofluorene and 2-acetyl-2-aminofluorene in rat liver DNA, Carcinogenesis, 2, 737, 10.1093/carcin/2.8.737 Weeks, 1980, Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulphotransferase and deacylase activities, and on mutations in Salmonella typhimurium TA1538, Cancer Res., 40, 1204 Weisburger, 1973, Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids, Pharmac. Rev., 25, 1 Williams, 1983, Effect of incubation and activation conditions on the hepatocyte-mediated plate incorporation and preincubation Salmonella typhimurium mutagenesis assays, Teratogen. Carcinogen. Mutagen., 3, 367, 10.1002/1520-6866(1990)3:4<367::AID-TCM1770030406>3.0.CO;2-C Wright, 1980, The role of metabolism in chemical mutagenesis and chemical carcinogenesis, Mutation Res., 75, 215, 10.1016/0165-1110(80)90017-2